
![]()
Novartis Oncology in Serbia
About Novartis Oncology Serbia
Oncology Business Unit has been independently present in Serbia since January 2003 and has been rapidly growing in recent years. Continuously striving for excellence, we provide significant benefit to patients as well as to health care providers in the oncology, hematology, urology, endocrinology and gastroenterology fields.
Our Activities
Our main task is improvement of health and quality of life of patients with following conditions: chronic myeloid leukemia, GIST, hormone responsive breast cancer, cancer-related bone disease, GEP/NET tumors, acromegaly and chronic iron overloading.
Our focus revolves around marketing of the following healthcare solutions:
- Glivec
- Femara
- Zometa
- Sandostatin / Sandostatin LAR
- Exjade
We incorporate the Global Novartis imperative: put patients first. Our commitment to high quality healthcare led to a strong partnership with Serbian CML Patients Society.
Contact Information
If you wish to contact Novartis Oncology Serbia, please use the information listed below:
Address:
Novartis Pharma Services Inc.
Bulevar Zorana �indica 71/V/15
11000 Belgrade
Serbia
Telephone: +381 11 2120 468
Novartis Oncology u Srbiji
Onkološki sektor je prisutan u Srbiji od Januara 2003. godine, pri cemu beleži znacajan rast u poslednjih nekoliko godina. U stalnoj želji za uspehom pružamo znacajanu podršku pacijentima, kao i strucnjacima u polju onkologije, hematologije, urologije, endokrinologije i gastroenterologije.
Naše aktivnosti
Naš glavni cilj je poboljšanje zdravlja i kvaliteta života pacijenata sa: hronicnom mijeloidnom leukemijom, GIST - om, hormon zavisnim karcinomom dojke, skeletnim komplikacijama uzrokovanim malignim obolenjima koje zahvataju kosti, GEP/NET tumorima, akromegalijom i hronicnim opterecenjem gvoždem.
Naša ambicija je da pomognemo pacijentima da nastave da se krecu kroz svakodnevan život.
Primarna aktivnost nam je vezana za marketing sledecih lekova:
- Glivec
- Femara
- Zometa
- Sandostatin / Sandostatin LAR
- Exjade
Mi sprovodimo globalni imperativ Novartisa: pacijent na prvom mestu. Posvecenost zdravstvenoj nezi visokog kvaliteta je dovela do snažne saradnje sa Udruženjem pacijenata sa hronicnom mijeloidnom leukemijom
Kontakt:
Ukoliko želite da kontaktirate Novartis Oncology u Srbiji, molimo vas da iskoristite navedene podatke:
Adresa:
Novartis Pharma Services Inc.
Bulevar Zorana Ðindica 71/V/15
11000 Belgrade
Serbia
Telefon: +381 11 2120 468
PRODUCTS
At Novartis Oncology, we strive to provide a broad range of innovative, practical solutions and authoritative resource therapies.
CAREERS AT NOVARTIS

Our success depends entirely on the creativity, performance and achievement of our associates at all levels.
RESEARCH INNOVATION
Novartis maintains the most promising oncology drug pipeline in the industry to treat and help people around the world.
STAY CONNECTED TO THE CANCER RESOURCE CENTER
Receive "Oncology in the News" by email weekly.